SCHEMBL4608402

SCHEMBL4608402

N#CCc1ccc(-c2ccc(C3CCCC3N)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM1A O60341 8/20 0.38
MAOB P27338 1/20 0.38
CTSC P53634 5/20 0.36
AXL P30530 2/20 0.35
MERTK Q12866 2/20 0.35
BACE1 P56817 1/20 0.35
KCNH2 Q12809 2/20 0.34
MAOA P21397 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MMP3 P08254 1/20 0.33
HDAC6 Q9UBN7 1/20 0.32
CYP11B2 P19099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4607730 0.80 KDM1A (0.49) KDM1AMAOBCTSCKCNH2MAOA
SCHEMBL4608400 0.79 SLC6A2 (0.40) ALDH1A1LMNAMAPTSMN1; SMN2CTSC
SCHEMBL4608169 0.78 MAOB (0.43) ALDH1A1KDM1AMAOBBACE1L3MBTL1
SCHEMBL4606554 0.75 KDM1A (0.66) LMNAKDM1AMAOBKCNH2MAOA
SCHEMBL10909081 0.74 MAPT (0.60) ALDH1A1LMNAMAPTSMN1; SMN2CTSC
SCHEMBL4607035 0.74 GRIA4 (0.48) ALDH1A1KDM1AMAOBCTSCKCNH2
SCHEMBL23578100 0.73 ALDH1A1 (0.58) ALDH1A1LMNAMAPTSMN1; SMN2L3MBTL1
SCHEMBL196175 0.72 MMP3 (0.50) L3MBTL1MMP3CYP11B2
SCHEMBL23137321 0.72 MMP3 (0.50) L3MBTL1MMP3CYP11B2
SCHEMBL4607516 0.71 GRIA4 (0.67) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP claimed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US claimed
EP-1246797-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP claimed
WO-2001042203-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-14 WO claimed
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP disclosed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US disclosed
EP-1246797-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP disclosed
WO-2001042203-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-14 WO disclosed